Testing a scoring system for Fuchs dystrophy and cataract surgery
Part of Eyes & vision, Genetic & congenital clinical trials.
This study tests a scoring system to predict how well people with Fuchs dystrophy do after cataract surgery. It may help doctors plan better treatment for your cornea and lens.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have Fuchs endothelial corneal dystrophy (a condition that affects the inner layer of the cornea) at a certain severity.
- You have a cataract (cloudy lens) that needs to be removed with surgery.
- You have not had any eye surgery before.
- You do not have other serious eye diseases that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the cornea (the clear front part of the eye) changes after cataract surgery in people with Fuchs' endothelial dystrophy, a condition that affects the inner layer of the cornea. It compares them to people without this condition to see if there are differences in corneal thickness after surgery.
This study compares two types of cataract surgery in people with Fuchs' dystrophy: one using a laser and the standard method. It looks at which approach gives better results for the cornea and vision.
This trial tests a surgical technique called Descemet membrane polishing during corneal transplant surgery for Fuchs endothelial corneal dystrophy, a condition that clouds the cornea (the clear front part of your eye). The study aims to see if this polishing step improves healing and vision after surgery.
This study tests whether special eye drops (Rho-kinase inhibitors) can improve the health of the cornea in people who have both Fuchs endothelial corneal dystrophy and glaucoma. The drops may help reduce corneal swelling and preserve your vision.
This trial tests an investigational eye drop (DT-168) in people with Fuchs endothelial corneal dystrophy who are already scheduled for a corneal transplant. The goal is to see if DT-168 can improve outcomes or delay the need for surgery.
This study tests special intraocular lenses (lenses placed inside the eye during cataract surgery) that are designed to work well in people who also need cornea transplantation (DMEK procedure). It aims to improve vision and reduce the need for glasses after surgery.
Hear when a new Fuchs Endothelial Corneal Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.